| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ZC3H15 OBSCN ITGA2B ITGAL ITGAV ITGB3 ITGB5 DSCAML1 SVEP1 CNTN5 NOS2 CNTN4 COMP DSP LAMB1 CDH19 ICAM5 EPHA2 DCHS1 MACF1 SCRIB PALLD | 3.91e-06 | 599 | 241 | 22 | GO:0050839 |
| GeneOntologyMolecularFunction | calcium ion binding | ADGRV1 PKD1L2 SVEP1 DHH PCDH10 FAT4 COMP PCDHGB5 FAT3 PCDHA12 PCDHA8 PCDHA6 RET CDH19 CELSR2 HMCN1 EDEM2 DCHS1 PITPNM3 MACF1 PCDH1 PCDH8 | 1.16e-04 | 749 | 241 | 22 | GO:0005509 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.51e-04 | 26 | 241 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 2.51e-04 | 26 | 241 | 4 | GO:0031420 | |
| GeneOntologyMolecularFunction | integrin binding | 2.84e-04 | 175 | 241 | 9 | GO:0005178 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 3.14e-04 | 76 | 241 | 6 | GO:0098631 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | BRIP1 KIF1A DHX9 ATAD2B MOV10L1 VCP RAD51 DNAH10 BTAF1 ATAD2 FBH1 HELZ2 MACF1 DDX20 YME1L1 | 3.21e-04 | 441 | 241 | 15 | GO:0016887 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DSCAML1 CNTN5 PCDH10 AMIGO2 CNTN4 FAT4 PCDHGB5 FAT3 PCDHA12 PCDHA8 PCDHA6 RET CDH19 CELSR2 HMCN1 DCHS1 IGSF9B PCDH1 PCDH8 PALLD | 7.10e-14 | 187 | 241 | 20 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | ITGAL DSCAML1 PTPRS CNTN5 PCDH10 AMIGO2 CNTN4 FAT4 PCDHGB5 FAT3 PCDHA12 PCDHA8 PCDHA6 RET CDH19 CELSR2 HMCN1 DCHS1 IGSF9B PCDH1 PCDH8 PALLD | 1.95e-11 | 313 | 241 | 22 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | HLA-DRB1 HLA-G ITGA2B ADGRV1 ITGAL ITGAV ITGB3 ITGB5 DSCAML1 SVEP1 BMP7 PTPRS CNTN5 PCDH10 AMIGO2 CNTN4 FAT4 COMP PCDHGB5 DSP FAT3 MINK1 LAMB1 PCDHA12 PCDHA8 PCDHA6 RET CDH19 HHLA2 CELSR2 HMCN1 ICAM5 DCHS1 IGSF9B SCRIB PCDH1 MUC4 PCDH8 PALLD | 2.87e-10 | 1077 | 241 | 39 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 1.14e-05 | 91 | 241 | 8 | GO:0033627 | |
| GeneOntologyBiologicalProcess | dendrite self-avoidance | 4.89e-05 | 18 | 241 | 4 | GO:0070593 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | HLA-B HLA-DRB1 APC2 HLA-G ITGA2B ITGAL ITGAV ITGB3 ITGB5 AP2A1 SCN1A SCN2A SCN8A KCNK6 C5 GP1BB GRIN2C GRIN2D RET CDH19 TGFBR3 SLC18A3 DCHS1 SCN3B | 1.65e-05 | 785 | 243 | 24 | GO:0098797 |
| GeneOntologyCellularComponent | integrin complex | 3.17e-05 | 32 | 243 | 5 | GO:0008305 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.76e-05 | 17 | 243 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 6.24e-05 | 59 | 243 | 6 | GO:0098636 | |
| GeneOntologyCellularComponent | lamellipodium membrane | 1.11e-04 | 22 | 243 | 4 | GO:0031258 | |
| GeneOntologyCellularComponent | integrin alphav-beta5 complex | 1.35e-04 | 2 | 243 | 2 | GO:0034684 | |
| GeneOntologyCellularComponent | sodium channel complex | 3.37e-04 | 29 | 243 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | alphav-beta3 integrin-PKCalpha complex | 4.01e-04 | 3 | 243 | 2 | GO:0035866 | |
| GeneOntologyCellularComponent | alphav-beta3 integrin-HMGB1 complex | 4.01e-04 | 3 | 243 | 2 | GO:0035868 | |
| GeneOntologyCellularComponent | integrin alphaIIb-beta3 complex | 4.01e-04 | 3 | 243 | 2 | GO:0070442 | |
| GeneOntologyCellularComponent | integrin alphav-beta3 complex | 4.01e-04 | 3 | 243 | 2 | GO:0034683 | |
| GeneOntologyCellularComponent | membrane protein complex | ERN1 HLA-B HLA-DRB1 APC2 HLA-G ITGA2B ITGAL ITGAV ITGB3 ITGB5 NDUFS1 DDOST MVB12A AP2A1 SCN1A SCN2A SCN8A KCNK6 C5 VCP GP1BB SYNE1 GRIN2C GRIN2D RET CDH19 SEC31B MFN1 TGFBR3 SLC18A3 DCHS1 SCN3B | 6.27e-04 | 1498 | 243 | 32 | GO:0098796 |
| GeneOntologyCellularComponent | striated muscle myosin thick filament | 7.95e-04 | 4 | 243 | 2 | GO:0005863 | |
| GeneOntologyCellularComponent | alphav-beta3 integrin-IGF-1-IGF1R complex | 7.95e-04 | 4 | 243 | 2 | GO:0035867 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 8.05e-04 | 94 | 243 | 6 | GO:0044291 | |
| GeneOntologyCellularComponent | perinucleolar compartment | 1.32e-03 | 5 | 243 | 2 | GO:0097356 | |
| GeneOntologyCellularComponent | node of Ranvier | 1.53e-03 | 20 | 243 | 3 | GO:0033268 | |
| HumanPheno | Lissencephaly | HIC1 PDHB APC2 SCN2A FAT4 NUP107 FKRP RTTN LAMB1 STIL CEP63 DCHS1 MACF1 | 9.02e-06 | 189 | 83 | 13 | HP:0001339 |
| HumanPheno | Abnormality of lower limb joint | BRIP1 ADAT3 HLA-B KIF1A ARSK KDM5C HLA-DRB1 APC2 SPART ADGRV1 ZNF469 SCN1A SCN2A HERC2 PIGO VCP GP1BB DNMT3A RAD51 COL6A3 FLNC FAT4 COMP NUP107 DSP FKRP SYNE1 UBE3B RTTN STIL RET SLC18A3 MACF1 | 2.88e-05 | 1027 | 83 | 33 | HP:0100491 |
| HumanPheno | Abnormality of the ankle | KIF1A APC2 SPART ADGRV1 SCN1A SCN2A VCP DNMT3A COL6A3 COMP SYNE1 RTTN | 5.38e-05 | 192 | 83 | 12 | HP:0003028 |
| HumanPheno | Limited knee extension | 6.20e-05 | 27 | 83 | 5 | HP:0003066 | |
| HumanPheno | EEG with spike-wave complexes | 7.89e-05 | 88 | 83 | 8 | HP:0010850 | |
| HumanPheno | Abnormal platelet membrane protein expression | 8.05e-05 | 6 | 83 | 3 | HP:0011878 | |
| Domain | Cadherin | PCDH10 FAT4 PCDHGB5 FAT3 PCDHA12 PCDHA8 PCDHA6 RET CDH19 CELSR2 DCHS1 PCDH1 PCDH8 | 2.20e-09 | 113 | 239 | 13 | PF00028 |
| Domain | - | PCDH10 FAT4 PCDHGB5 FAT3 PCDHA12 PCDHA8 PCDHA6 RET CDH19 CELSR2 DCHS1 PCDH1 PCDH8 | 2.46e-09 | 114 | 239 | 13 | 2.60.40.60 |
| Domain | CADHERIN_2 | PCDH10 FAT4 PCDHGB5 FAT3 PCDHA12 PCDHA8 PCDHA6 RET CDH19 CELSR2 DCHS1 PCDH1 PCDH8 | 2.46e-09 | 114 | 239 | 13 | PS50268 |
| Domain | CA | PCDH10 FAT4 PCDHGB5 FAT3 PCDHA12 PCDHA8 PCDHA6 RET CDH19 CELSR2 DCHS1 PCDH1 PCDH8 | 2.74e-09 | 115 | 239 | 13 | SM00112 |
| Domain | Cadherin-like | PCDH10 FAT4 PCDHGB5 FAT3 PCDHA12 PCDHA8 PCDHA6 RET CDH19 CELSR2 DCHS1 PCDH1 PCDH8 | 3.05e-09 | 116 | 239 | 13 | IPR015919 |
| Domain | Cadherin | PCDH10 FAT4 PCDHGB5 FAT3 PCDHA12 PCDHA8 PCDHA6 RET CDH19 CELSR2 DCHS1 PCDH1 PCDH8 | 3.77e-09 | 118 | 239 | 13 | IPR002126 |
| Domain | Cadherin_CS | PCDH10 FAT4 PCDHGB5 FAT3 PCDHA12 PCDHA8 PCDHA6 CDH19 CELSR2 DCHS1 PCDH1 PCDH8 | 1.53e-08 | 109 | 239 | 12 | IPR020894 |
| Domain | CADHERIN_1 | PCDH10 FAT4 PCDHGB5 FAT3 PCDHA12 PCDHA8 PCDHA6 CDH19 CELSR2 DCHS1 PCDH1 PCDH8 | 2.31e-08 | 113 | 239 | 12 | PS00232 |
| Domain | FN3 | TSPOAP1 OBSCN DSCAML1 PTPRS CNTN5 CNTN4 COL6A3 FLNC EPHA2 IGSF9B SORL1 MYBPC3 | 4.85e-06 | 185 | 239 | 12 | SM00060 |
| Domain | EGF-like_CS | ITGB3 ITGB5 SVEP1 FAT4 COMP FAT3 LAMB1 CELSR2 HMCN1 EPHA2 ATRNL1 CSPG5 MUC4 SORL1 | 7.22e-06 | 261 | 239 | 14 | IPR013032 |
| Domain | EGF_2 | ITGB3 ITGB5 SVEP1 FAT4 COMP FAT3 LAMB1 CELSR2 HMCN1 EPHA2 ATRNL1 CSPG5 MUC4 SORL1 | 8.59e-06 | 265 | 239 | 14 | PS01186 |
| Domain | Integrin_dom | 1.42e-05 | 25 | 239 | 5 | IPR032695 | |
| Domain | - | HLA-B TSPOAP1 HLA-DRB1 HLA-G OBSCN DSCAML1 PTPRS CNTN5 AMIGO2 CNTN4 COL6A3 FLNC PKHD1L1 HHLA2 HMCN1 ICAM5 EPHA2 WFIKKN2 IGSF9B PALLD SCN3B SORL1 MYBPC3 | 1.51e-05 | 663 | 239 | 23 | 2.60.40.10 |
| Domain | FN3_dom | TSPOAP1 OBSCN DSCAML1 PTPRS CNTN5 CNTN4 COL6A3 FLNC EPHA2 IGSF9B SORL1 MYBPC3 | 1.67e-05 | 209 | 239 | 12 | IPR003961 |
| Domain | Cadherin_2 | 1.91e-05 | 65 | 239 | 7 | PF08266 | |
| Domain | Cadherin_N | 1.91e-05 | 65 | 239 | 7 | IPR013164 | |
| Domain | Ig_I-set | OBSCN DSCAML1 PTPRS CNTN5 CNTN4 HMCN1 ICAM5 WFIKKN2 IGSF9B PALLD MYBPC3 | 3.49e-05 | 190 | 239 | 11 | IPR013098 |
| Domain | I-set | OBSCN DSCAML1 PTPRS CNTN5 CNTN4 HMCN1 ICAM5 WFIKKN2 IGSF9B PALLD MYBPC3 | 3.49e-05 | 190 | 239 | 11 | PF07679 |
| Domain | Na_trans_cytopl | 4.02e-05 | 6 | 239 | 3 | IPR024583 | |
| Domain | - | 4.02e-05 | 6 | 239 | 3 | 3.90.1290.10 | |
| Domain | Na_trans_cytopl | 4.02e-05 | 6 | 239 | 3 | PF11933 | |
| Domain | Ig-like_fold | HLA-B TSPOAP1 HLA-DRB1 HLA-G OBSCN DSCAML1 PTPRS CNTN5 AMIGO2 CNTN4 COL6A3 FLNC PKHD1L1 HHLA2 HMCN1 ICAM5 EPHA2 WFIKKN2 IGSF9B PALLD SCN3B SORL1 MYBPC3 | 4.04e-05 | 706 | 239 | 23 | IPR013783 |
| Domain | fn3 | TSPOAP1 OBSCN DSCAML1 PTPRS CNTN5 CNTN4 EPHA2 IGSF9B SORL1 MYBPC3 | 4.61e-05 | 162 | 239 | 10 | PF00041 |
| Domain | EGF | ITGB5 SVEP1 FAT4 COMP FAT3 LAMB1 CELSR2 HMCN1 ATRNL1 CSPG5 MUC4 SORL1 | 5.29e-05 | 235 | 239 | 12 | SM00181 |
| Domain | FN3 | TSPOAP1 OBSCN DSCAML1 PTPRS CNTN5 CNTN4 COL6A3 EPHA2 IGSF9B SORL1 MYBPC3 | 5.32e-05 | 199 | 239 | 11 | PS50853 |
| Domain | Plectin | 6.97e-05 | 7 | 239 | 3 | PF00681 | |
| Domain | Plectin_repeat | 6.97e-05 | 7 | 239 | 3 | IPR001101 | |
| Domain | PLEC | 6.97e-05 | 7 | 239 | 3 | SM00250 | |
| Domain | VWFA | 8.66e-05 | 82 | 239 | 7 | PS50234 | |
| Domain | VWA | 1.01e-04 | 84 | 239 | 7 | SM00327 | |
| Domain | EGF_1 | ITGB3 ITGB5 SVEP1 FAT4 COMP FAT3 LAMB1 CELSR2 HMCN1 ATRNL1 CSPG5 MUC4 | 1.15e-04 | 255 | 239 | 12 | PS00022 |
| Domain | IG_LIKE | HLA-B HLA-DRB1 HLA-G OBSCN DSCAML1 PTPRS CNTN5 AMIGO2 CNTN4 HHLA2 HMCN1 ICAM5 WFIKKN2 IGSF9B PALLD SCN3B MYBPC3 | 2.07e-04 | 491 | 239 | 17 | PS50835 |
| Domain | IGc2 | OBSCN DSCAML1 PTPRS CNTN5 CNTN4 HMCN1 ICAM5 WFIKKN2 IGSF9B PALLD MYBPC3 | 2.32e-04 | 235 | 239 | 11 | SM00408 |
| Domain | Ig_sub2 | OBSCN DSCAML1 PTPRS CNTN5 CNTN4 HMCN1 ICAM5 WFIKKN2 IGSF9B PALLD MYBPC3 | 2.32e-04 | 235 | 239 | 11 | IPR003598 |
| Domain | A2M | 2.32e-04 | 10 | 239 | 3 | PF00207 | |
| Domain | A2M_N_2 | 2.32e-04 | 10 | 239 | 3 | IPR011625 | |
| Domain | A2M_comp | 2.32e-04 | 10 | 239 | 3 | IPR011626 | |
| Domain | A2M_recep | 2.32e-04 | 10 | 239 | 3 | PF07677 | |
| Domain | A2M_comp | 2.32e-04 | 10 | 239 | 3 | PF07678 | |
| Domain | A2M_N_2 | 2.32e-04 | 10 | 239 | 3 | PF07703 | |
| Domain | Na_channel_asu | 2.32e-04 | 10 | 239 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 2.32e-04 | 10 | 239 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 2.32e-04 | 10 | 239 | 3 | PF06512 | |
| Domain | A2M_N | 2.32e-04 | 10 | 239 | 3 | PF01835 | |
| Domain | A2M_N | 2.32e-04 | 10 | 239 | 3 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 2.32e-04 | 10 | 239 | 3 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 2.32e-04 | 10 | 239 | 3 | PS00477 | |
| Domain | Macroglobln_a2 | 2.32e-04 | 10 | 239 | 3 | IPR001599 | |
| Domain | Ig-like_dom | HLA-B HLA-DRB1 HLA-G OBSCN DSCAML1 PTPRS CNTN5 AMIGO2 CNTN4 HHLA2 HMCN1 ICAM5 WFIKKN2 IGSF9B PALLD SCN3B MYBPC3 | 2.75e-04 | 503 | 239 | 17 | IPR007110 |
| Domain | VWF_A | 2.82e-04 | 99 | 239 | 7 | IPR002035 | |
| Domain | Integrin_alpha | 3.16e-04 | 11 | 239 | 3 | PF00357 | |
| Domain | - | 3.70e-04 | 74 | 239 | 6 | 3.40.50.410 | |
| Domain | EGF-like_dom | SVEP1 FAT4 COMP FAT3 LAMB1 CELSR2 HMCN1 ATRNL1 CSPG5 MUC4 SORL1 | 3.80e-04 | 249 | 239 | 11 | IPR000742 |
| Domain | ATPase_AAA_CS | 4.83e-04 | 29 | 239 | 4 | IPR003960 | |
| Domain | SPEC | 7.10e-04 | 32 | 239 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 7.10e-04 | 32 | 239 | 4 | IPR018159 | |
| Domain | AAA | 8.97e-04 | 34 | 239 | 4 | PS00674 | |
| Domain | EGF_3 | 9.27e-04 | 235 | 239 | 10 | PS50026 | |
| Domain | - | 9.62e-04 | 4 | 239 | 2 | 1.20.5.630 | |
| Domain | RNase_II/R_CS | 9.62e-04 | 4 | 239 | 2 | IPR022966 | |
| Domain | GPS | 1.00e-03 | 35 | 239 | 4 | PF01825 | |
| Domain | Integrin_alpha_C_CS | 1.02e-03 | 16 | 239 | 3 | IPR018184 | |
| Domain | IG | OBSCN DSCAML1 PTPRS CNTN5 AMIGO2 CNTN4 HHLA2 HMCN1 ICAM5 WFIKKN2 IGSF9B PALLD SCN3B MYBPC3 | 1.10e-03 | 421 | 239 | 14 | SM00409 |
| Domain | Ig_sub | OBSCN DSCAML1 PTPRS CNTN5 AMIGO2 CNTN4 HHLA2 HMCN1 ICAM5 WFIKKN2 IGSF9B PALLD SCN3B MYBPC3 | 1.10e-03 | 421 | 239 | 14 | IPR003599 |
| Domain | GPS | 1.12e-03 | 36 | 239 | 4 | PS50221 | |
| Domain | Cadherin_tail | 1.24e-03 | 37 | 239 | 4 | PF15974 | |
| Domain | Cadherin_CBD | 1.24e-03 | 37 | 239 | 4 | IPR031904 | |
| Domain | GPS | 1.24e-03 | 37 | 239 | 4 | IPR000203 | |
| Domain | - | 1.39e-03 | 95 | 239 | 6 | 2.60.120.200 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 1.46e-03 | 18 | 239 | 3 | IPR008930 | |
| Domain | INTEGRIN_ALPHA | 1.46e-03 | 18 | 239 | 3 | PS00242 | |
| Domain | Integrin_alpha | 1.46e-03 | 18 | 239 | 3 | IPR000413 | |
| Domain | Integrin_alpha-2 | 1.46e-03 | 18 | 239 | 3 | IPR013649 | |
| Domain | Integrin_alpha2 | 1.46e-03 | 18 | 239 | 3 | PF08441 | |
| Domain | - | BRIP1 DHX9 RAB33A NWD2 ATAD2B MOV10L1 HS3ST6 RAB39B VCP RAD51 DNAH10 MTHFD1L BTAF1 ATAD2 MFN1 FBH1 HELZ2 DDX20 YME1L1 HYDIN | 1.52e-03 | 746 | 239 | 20 | 3.40.50.300 |
| Domain | Int_alpha | 1.72e-03 | 19 | 239 | 3 | SM00191 | |
| Domain | Int_alpha_beta-p | 1.72e-03 | 19 | 239 | 3 | IPR013519 | |
| Domain | Integrin_b_cyt | 2.36e-03 | 6 | 239 | 2 | SM01241 | |
| Domain | Integrin_b_cyt | 2.36e-03 | 6 | 239 | 2 | PF08725 | |
| Domain | Integrin_bsu_cyt_dom | 2.36e-03 | 6 | 239 | 2 | IPR014836 | |
| Domain | AAA+_ATPase | 2.57e-03 | 144 | 239 | 7 | IPR003593 | |
| Domain | AAA | 2.57e-03 | 144 | 239 | 7 | SM00382 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.01e-06 | 76 | 178 | 8 | M27219 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.06e-05 | 84 | 178 | 8 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.16e-05 | 85 | 178 | 8 | M16441 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 1.61e-05 | 26 | 178 | 5 | M47 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.24e-05 | 121 | 178 | 9 | M872 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.77e-05 | 76 | 178 | 7 | MM14867 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL22A1 ITGA2B ITGAL ITGAV ITGB3 ITGB5 BMP7 PTPRS KLKB1 COL6A3 COMP LAMB1 ICAM5 | 1.13e-04 | 300 | 178 | 13 | M610 |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 1.48e-04 | 121 | 178 | 8 | M39823 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 1.80e-04 | 23 | 178 | 4 | M47720 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 1.80e-04 | 23 | 178 | 4 | M47537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 2.96e-04 | 26 | 178 | 4 | M47719 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.03e-04 | 47 | 178 | 5 | MM14925 | |
| Pathway | WP_DRAVET_SYNDROME | 3.97e-04 | 28 | 178 | 4 | M45519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 3.97e-04 | 28 | 178 | 4 | M47655 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 SETD1B PPRC1 SHISA5 OBSCN ITGB5 ZGPAT AP2A1 PTPRS CSAD SCN8A HERC2 DOCK6 RAD51 FLNC CRYBG2 RTL6 RASA3 MTHFD1L POLR2A UBE3B UBR4 RTTN ICE1 BTAF1 GRIN2D TLNRD1 LLGL2 CELSR2 HELZ2 ENDOG CYB5R2 ARHGAP33 | 3.87e-12 | 1105 | 247 | 33 | 35748872 |
| Pubmed | HLA-B KIF1A PDHB PPRC1 HLA-DRB1 APC2 MCF2L2 DSCAML1 AP2A1 HERC2 BACE2 CARS2 MAP4K4 VCP CNTN4 DSP SYNE1 SGTA UBR4 LAMB1 XPC DNAAF9 SEC31B CEP63 CS FBH1 ATRNL1 MACF1 SCRIB DNAI7 PCCB YME1L1 TRIM37 XPOT | 4.68e-11 | 1285 | 247 | 34 | 35914814 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 DIS3L2 SETD1B PDHB BCAS2 NDUFS1 DDOST DHX9 CDCA2 ZGPAT AP2A1 SERPINB12 PPP1R37 HERC2 VCP FLNC NUP107 RASA3 DSP MTHFD1L POLR2A UBR4 PPIL4 XPC ATAD2 CS PDE12 MACF1 DDX20 SCRIB YME1L1 PALLD TP53BP1 XPOT | 1.82e-10 | 1353 | 247 | 34 | 29467282 |
| Pubmed | DCAF1 QPCTL PDHB BCAS2 ZC3H15 SPART NDUFS1 DDOST DHX9 NUP210 PWP2 HERC2 CARS2 MAP4K4 VCP NUP107 MTHFD1L SYNE1 SGTA MINK1 UBR4 LAMB1 CPD MAP7 NFS1 AKAP12 PDE12 EPHA2 MACF1 SCRIB ENDOG YME1L1 TP53BP1 TPD52L2 | 2.05e-09 | 1487 | 247 | 34 | 33957083 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | DCAF1 KDM5C PTPRS BOD1L1 HERC2 MAP4K4 FLNC POLR2A UBR4 CPD FMNL3 EPHA2 DDX20 SCRIB XPOT | 8.71e-09 | 313 | 247 | 15 | 38270169 |
| Pubmed | 1.32e-08 | 12 | 247 | 5 | 19693543 | ||
| Pubmed | 2.13e-08 | 13 | 247 | 5 | 23874206 | ||
| Pubmed | SPART ITGAL DDOST DHX9 ZNF469 AP2A1 SESN2 TSR3 VCP POLR2A PPIL4 BTAF1 MAP7 NFS1 MFN1 SPAG5 PDE12 SCRIB PALLD XPOT | 5.62e-08 | 653 | 247 | 20 | 33742100 | |
| Pubmed | EPPK1 KIF1A NDUFS1 ATAD2B NUP210 PWP2 HERC2 VCP FLNC NUP107 DSP MTHFD1L POLR2A UBR4 ATAD2 HELZ2 MACF1 DDX20 TP53BP1 XPOT | 5.62e-08 | 653 | 247 | 20 | 22586326 | |
| Pubmed | 7.97e-08 | 77 | 247 | 8 | 10835267 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 1.08e-07 | 80 | 247 | 8 | 10716726 | |
| Pubmed | 3.04e-07 | 9 | 247 | 4 | 25063885 | ||
| Pubmed | 3.54e-07 | 3 | 247 | 3 | 18985734 | ||
| Pubmed | 3.54e-07 | 3 | 247 | 3 | 12031826 | ||
| Pubmed | Targeting ανβ3 and ανβ5 inhibits photon-induced hypermigration of malignant glioma cells. | 3.54e-07 | 3 | 247 | 3 | 21978494 | |
| Pubmed | 3.54e-07 | 3 | 247 | 3 | 28518218 | ||
| Pubmed | 3.54e-07 | 3 | 247 | 3 | 10891446 | ||
| Pubmed | 3.54e-07 | 3 | 247 | 3 | 19888429 | ||
| Pubmed | 3.54e-07 | 3 | 247 | 3 | 22074485 | ||
| Pubmed | 3.54e-07 | 3 | 247 | 3 | 32845893 | ||
| Pubmed | 3.54e-07 | 3 | 247 | 3 | 17928448 | ||
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 8.32e-07 | 72 | 247 | 7 | 10380929 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | PDHB BCAS2 ZC3H15 NDUFS1 DDOST DHX9 NWD2 AP2A1 TSR3 PZP DOCK6 MAP4K4 VCP DNMT3A FLNC DSP SYNE1 POLR2A PPIL4 XPC KCTD3 HELZ2 MACF1 ARHGAP33 | 9.76e-07 | 1082 | 247 | 24 | 38697112 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 1.00e-06 | 74 | 247 | 7 | 10817752 | |
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 1.18e-06 | 12 | 247 | 4 | 30175250 | |
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 1.23e-06 | 27 | 247 | 5 | 31541017 | |
| Pubmed | QPCTL PDHB NDUFS1 DDOST DHX9 NUP210 HERC2 VCP NUP107 DSP SGTA UBR4 LAMB1 CPD BTAF1 AKAP12 DDX20 XPOT | 1.31e-06 | 657 | 247 | 18 | 36180527 | |
| Pubmed | 1.41e-06 | 4 | 247 | 3 | 17537961 | ||
| Pubmed | 1.41e-06 | 4 | 247 | 3 | 9849968 | ||
| Pubmed | 1.41e-06 | 4 | 247 | 3 | 35031483 | ||
| Pubmed | 1.41e-06 | 4 | 247 | 3 | 29578003 | ||
| Pubmed | αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer. | 1.41e-06 | 4 | 247 | 3 | 25150423 | |
| Pubmed | 1.41e-06 | 4 | 247 | 3 | 21156207 | ||
| Pubmed | Expression pattern of alphavbeta3 and alphavbeta5 integrin mRNA in mouse fetal gonads. | 1.41e-06 | 4 | 247 | 3 | 16571912 | |
| Pubmed | Expression of integrins in cerebral arteriovenous and cavernous malformations. | 1.41e-06 | 4 | 247 | 3 | 16385340 | |
| Pubmed | 1.41e-06 | 4 | 247 | 3 | 23152803 | ||
| Pubmed | 1.41e-06 | 4 | 247 | 3 | 20033473 | ||
| Pubmed | 1.41e-06 | 4 | 247 | 3 | 7525578 | ||
| Pubmed | 1.41e-06 | 4 | 247 | 3 | 24639195 | ||
| Pubmed | 1.41e-06 | 4 | 247 | 3 | 7682219 | ||
| Pubmed | 1.41e-06 | 4 | 247 | 3 | 22308022 | ||
| Pubmed | 1.41e-06 | 4 | 247 | 3 | 17468108 | ||
| Pubmed | 1.41e-06 | 4 | 247 | 3 | 19255147 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPPK1 DDOST DHX9 AP2A1 MOV10L1 SCN8A VCP FLNC DSP SYNE1 POLR2A UBR4 PCDHA8 SPAG5 CS LLGL2 MACF1 PCCB HYDIN XPOT | 1.56e-06 | 807 | 247 | 20 | 30575818 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | KIF1A HLA-G OBSCN DSCAML1 DDOST DHX9 ATAD2B SCN8A BOD1L1 PCDH10 FAT4 DSP POLR2A UBR4 ICE1 PDE12 PITPNM3 IGSF9B SCRIB | 1.59e-06 | 736 | 247 | 19 | 29676528 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | QPCTL HLA-B ARSK ITGAV ITGB5 DDOST PTPRS NUP210 BACE2 PIGO VCP AMIGO2 FAT4 FKRP LAMB1 CPD MAP7 SPAG5 CELSR2 EPHA2 EDEM2 SCRIB PALLD MSLN SORL1 | 1.79e-06 | 1201 | 247 | 25 | 35696571 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | SETD1B KIF1A ZC3H15 DHX9 NWD2 SCN8A HERC2 PZP VCP DSP POLR2A UBR4 DDX20 IGSF9B TP53BP1 | 1.85e-06 | 475 | 247 | 15 | 31040226 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | EPPK1 TSPOAP1 APC2 TSC22D2 ITGB3 OTUD7B ZNF469 SCN1A UBR4 RET PRX IGSF9B ENDOG RUNDC1 | 2.88e-06 | 430 | 247 | 14 | 35044719 |
| Pubmed | 3.50e-06 | 5 | 247 | 3 | 17320454 | ||
| Pubmed | 3.50e-06 | 5 | 247 | 3 | 11812775 | ||
| Pubmed | 3.50e-06 | 5 | 247 | 3 | 1679748 | ||
| Pubmed | HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin. | 3.50e-06 | 5 | 247 | 3 | 20826760 | |
| Pubmed | 3.50e-06 | 5 | 247 | 3 | 21344378 | ||
| Pubmed | 3.50e-06 | 5 | 247 | 3 | 11331301 | ||
| Pubmed | 3.50e-06 | 5 | 247 | 3 | 22879933 | ||
| Pubmed | The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis. | 3.50e-06 | 5 | 247 | 3 | 18648521 | |
| Pubmed | 3.50e-06 | 5 | 247 | 3 | 19695571 | ||
| Pubmed | 3.50e-06 | 5 | 247 | 3 | 11927607 | ||
| Pubmed | Basic amino-acid side chains regulate transmembrane integrin signalling. | 3.50e-06 | 5 | 247 | 3 | 22178926 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | HLA-G ITGAV ITGB3 ITGB5 PTPRS MAP4K4 RASA3 MINK1 AKAP12 FMNL3 EPHA2 SCRIB PCDH1 | 3.53e-06 | 377 | 247 | 13 | 38117590 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | QPCTL KIF1A DDOST MED24 AP2A1 NUP210 VCP GP1BB NUP107 FKRP SGTA UBR4 CPD BTAF1 SPAG5 PDE12 EPHA2 DDX20 SCRIB YME1L1 XPOT | 4.44e-06 | 942 | 247 | 21 | 31073040 |
| Pubmed | EPPK1 BCAS2 ZC3H15 SPART ITGAV NDUFS1 DDOST DHX9 AP2A1 NUP210 BOD1L1 CARS2 PIGO VCP DSP MTHFD1L UBR4 LAMB1 CPD MAP7 AKAP12 MACF1 PALLD TP53BP1 XPOT | 6.84e-06 | 1297 | 247 | 25 | 33545068 | |
| Pubmed | 6.97e-06 | 6 | 247 | 3 | 19570064 | ||
| Pubmed | 6.97e-06 | 6 | 247 | 3 | 18550570 | ||
| Pubmed | Integrins take partners: cross-talk between integrins and other membrane receptors. | 6.97e-06 | 6 | 247 | 3 | 9789327 | |
| Pubmed | Ethanol increases fetal human neurosphere size and alters adhesion molecule gene expression. | 6.97e-06 | 6 | 247 | 3 | 18162078 | |
| Pubmed | 6.97e-06 | 6 | 247 | 3 | 24216753 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 6.97e-06 | 6 | 247 | 3 | 23652591 | |
| Pubmed | 6.97e-06 | 6 | 247 | 3 | 21529934 | ||
| Pubmed | 6.97e-06 | 6 | 247 | 3 | 12358597 | ||
| Pubmed | Periostin supports hematopoietic progenitor cells and niche-dependent myeloblastoma cells in vitro. | 6.97e-06 | 6 | 247 | 3 | 27596966 | |
| Pubmed | 6.97e-06 | 6 | 247 | 3 | 1694173 | ||
| Pubmed | The allele frequencies of HPA 1-16 determined by PCR-SSP in Chinese Cantonese donors. | 6.97e-06 | 6 | 247 | 3 | 20667040 | |
| Pubmed | 6.97e-06 | 6 | 247 | 3 | 8601592 | ||
| Pubmed | 6.97e-06 | 6 | 247 | 3 | 23789102 | ||
| Pubmed | Genetic control of diabetogenesis in NOD/Lt mice. Development and analysis of congenic stocks. | 8.85e-06 | 19 | 247 | 4 | 2576007 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 9.15e-06 | 68 | 247 | 6 | 11230163 | |
| Pubmed | WSB1 DIS3L2 SETD1B PDHB INPP5B KDM5C HMGCS1 TSC22D2 CDK14 ITGB5 NDUFS1 DDOST MED24 SESN2 MAP4K4 RAD51 COMP SGTA UBR4 ATAD2 TLNRD1 CS LLGL2 EDEM2 RUNDC1 | 1.01e-05 | 1327 | 247 | 25 | 32694731 | |
| Pubmed | 1.02e-05 | 242 | 247 | 10 | 34011540 | ||
| Pubmed | ITGAV AP2A1 PPP1R37 MAP4K4 RASA3 MINK1 CPD AKAP12 LLGL2 CELSR2 EPHA2 MACF1 SCRIB | 1.15e-05 | 421 | 247 | 13 | 36976175 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KIF1A PDHB ZC3H15 NDUFS1 DDOST DHX9 CDCA2 AP2A1 SERPINB12 NUP210 PWP2 BOD1L1 MAP4K4 NUP107 DNAH10 DSP MTHFD1L SYNE1 POLR2A UBR4 PPIL4 ATAD2 CS PDE12 DDX20 XPOT | 1.16e-05 | 1425 | 247 | 26 | 30948266 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DCAF1 NDUFS1 DDOST OTUD7B USP38 PWP2 PKLR HERC2 MAP4K4 VCP TAF1D FLNC MTHFD1L SGTA PPIL4 ICE1 CS PDE12 KCTD3 SCRIB TP53BP1 | 1.18e-05 | 1005 | 247 | 21 | 19615732 |
| Pubmed | 1.21e-05 | 7 | 247 | 3 | 21051860 | ||
| Pubmed | 1.21e-05 | 7 | 247 | 3 | 16059920 | ||
| Pubmed | 1.21e-05 | 7 | 247 | 3 | 10048576 | ||
| Pubmed | 1.21e-05 | 7 | 247 | 3 | 10091056 | ||
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 1.21e-05 | 7 | 247 | 3 | 25818041 | |
| Pubmed | Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. | 1.21e-05 | 7 | 247 | 3 | 15284116 | |
| Pubmed | 1.21e-05 | 7 | 247 | 3 | 10438928 | ||
| Pubmed | The C-type lectin domain of CD62P (P-selectin) functions as an integrin ligand. | 1.21e-05 | 7 | 247 | 3 | 37184585 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FILIP1 BRIP1 KDM5C DHX9 OTUD7B MED24 MAP4K4 DSP SGTA POLR2A MINK1 XPC BTAF1 ATAD2 HELZ2 DDX20 SCRIB TP53BP1 | 1.24e-05 | 774 | 247 | 18 | 15302935 |
| Pubmed | FILIP1 KDM5C DHX9 NUP210 HERC2 DNMT3A NUP107 HELZ2 TUBD1 TP53BP1 | 1.35e-05 | 250 | 247 | 10 | 33536335 | |
| Pubmed | NUP210 PLIN4 CNTN4 WDFY4 PRX SLC45A4 ATRNL1 DNAH17 HELZ2 MACF1 ARHGAP28 PALLD SCN3B DOP1A | 1.36e-05 | 493 | 247 | 14 | 15368895 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.56e-05 | 202 | 247 | 9 | 33005030 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | HLA-B ARSK PDHB HLA-G ITGAV SLC30A4 ITGB5 NDUFS1 DDOST GVINP1 CARS2 MAP4K4 PIGO VCP PLIN4 FLNC DSP MTHFD1L PPIL4 LAMB1 CCDC80 CPD NFS1 CS PDE12 CELSR2 | 1.58e-05 | 1451 | 247 | 26 | 30550785 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPPK1 HLA-B PDHB BCAS2 ZC3H15 SPART HMGCS1 AP2A1 SERPINB12 NNMT VCP FLNC DSP MTHFD1L SGTA UBR4 AKAP12 CS PDE12 EPHA2 DDX20 SCRIB PALLD TP53BP1 TPD52L2 | 1.66e-05 | 1367 | 247 | 25 | 32687490 |
| Pubmed | Genetic polymorphisms associated with priapism in sickle cell disease. | 1.93e-05 | 8 | 247 | 3 | 17408468 | |
| Pubmed | Serial backcross analysis of genetic resistance to mousepox, using marker loci for Rmp-2 and Rmp-3. | 1.93e-05 | 8 | 247 | 3 | 1433507 | |
| Pubmed | 1.93e-05 | 8 | 247 | 3 | 16005200 | ||
| Pubmed | αv Integrins combine with LC3 and atg5 to regulate Toll-like receptor signalling in B cells. | 1.93e-05 | 8 | 247 | 3 | 26965188 | |
| Interaction | C2CD4B interactions | 8.43e-07 | 44 | 241 | 7 | int:C2CD4B | |
| Interaction | CD160 interactions | 1.55e-06 | 48 | 241 | 7 | int:CD160 | |
| Interaction | SPSB4 interactions | 2.46e-06 | 124 | 241 | 10 | int:SPSB4 | |
| Interaction | XAGE1A interactions | 8.70e-06 | 41 | 241 | 6 | int:XAGE1A | |
| Interaction | LOC254896 interactions | 1.16e-05 | 43 | 241 | 6 | int:LOC254896 | |
| Interaction | TOP3B interactions | EPPK1 SETD1B PPRC1 SHISA5 OBSCN ITGB5 DHX9 ZGPAT AP2A1 PTPRS CSAD SCN8A HERC2 TSR3 DOCK6 RAD51 FLNC CRYBG2 RTL6 RASA3 MTHFD1L POLR2A UBE3B UBR4 RTTN ICE1 BTAF1 GRIN2D TLNRD1 LLGL2 CELSR2 HELZ2 DDX20 ENDOG CYB5R2 ARHGAP33 TP53BP1 | 1.32e-05 | 1470 | 241 | 37 | int:TOP3B |
| Interaction | COX8A interactions | PDHB NDUFS1 ACOT2 CARS2 VCP NUP107 MTHFD1L CPD XPC NFS1 CS PDE12 YME1L1 TPD52L2 | 3.59e-05 | 322 | 241 | 14 | int:COX8A |
| GeneFamily | Fibronectin type III domain containing | TSPOAP1 OBSCN DSCAML1 PTPRS CNTN5 PTPRQ CNTN4 EPHA2 IGSF9B SORL1 MYBPC3 | 4.29e-07 | 160 | 174 | 11 | 555 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | OBSCN DSCAML1 PTPRS CNTN5 CNTN4 HMCN1 WFIKKN2 IGSF9B PALLD MYBPC3 | 3.65e-06 | 161 | 174 | 10 | 593 |
| GeneFamily | Cadherin related | 1.79e-05 | 17 | 174 | 4 | 24 | |
| GeneFamily | EF-hand domain containing|Plakins | 4.74e-05 | 8 | 174 | 3 | 939 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 7.05e-05 | 9 | 174 | 3 | 1234 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 7.05e-05 | 9 | 174 | 3 | 1203 | |
| GeneFamily | Non-clustered protocadherins | 1.81e-04 | 12 | 174 | 3 | 21 | |
| GeneFamily | Membrane associated guanylate kinases|PDZ domain containing|Scribble complex | 5.46e-04 | 4 | 174 | 2 | 1224 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 6.43e-04 | 18 | 174 | 3 | 1160 | |
| GeneFamily | C1-set domain containing | 6.97e-04 | 42 | 174 | 4 | 591 | |
| GeneFamily | AAA ATPases | 1.68e-03 | 53 | 174 | 4 | 413 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 1.87e-03 | 7 | 174 | 2 | 1201 | |
| GeneFamily | CD molecules|Integrin beta subunits | 3.17e-03 | 9 | 174 | 2 | 1159 | |
| GeneFamily | Clustered protocadherins | 3.36e-03 | 64 | 174 | 4 | 20 | |
| GeneFamily | UPF1 like RNA helicases | 4.78e-03 | 11 | 174 | 2 | 1169 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_UP | 2.00e-05 | 199 | 246 | 10 | M8255 | |
| Coexpression | LEE_NEURAL_CREST_STEM_CELL_DN | 2.06e-05 | 122 | 246 | 8 | M10276 | |
| Coexpression | GSE13306_TREG_RA_VS_TCONV_RA_DN | 2.09e-05 | 200 | 246 | 10 | M3227 | |
| Coexpression | GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP | QPCTL TSPOAP1 ITGB5 CDCA2 SCN1A PCDHA12 STIL SPAG5 ICAM5 PCDH8 | 2.09e-05 | 200 | 246 | 10 | M6057 |
| Coexpression | GSE7460_TCONV_VS_TREG_LN_UP | SLC30A4 ITGB3 AMIGO2 RASA3 SYNE1 MAP7 AKAP12 TGFBR3 WFIKKN2 ENDOG | 2.09e-05 | 200 | 246 | 10 | M5673 |
| Coexpression | DESCARTES_FETAL_LIVER_STELLATE_CELLS | 2.15e-05 | 160 | 246 | 9 | M40233 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 2.49e-05 | 163 | 246 | 9 | M8235 | |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | INPP5B ITGAL PZP FYB2 SPATA6L DNAH10 RASA3 SYNE1 HHLA2 MACF1 DNAI7 CSMD1 ENDOG TRIM37 HYDIN | 3.23e-05 | 459 | 246 | 15 | M39136 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | EPPK1 QPCTL HLA-B SHISA5 HLA-G DDOST PTPRS PIGO VCP TAF1D FLNC LAMB1 CPD SLC45A4 TGFBR3 HELZ2 PCDH1 MSLN XPOT | 4.03e-05 | 703 | 246 | 19 | MM1055 |
| Coexpression | FEKIR_HEPARG_SPHERE_VS_HEPARG_UP | 5.43e-05 | 103 | 246 | 7 | M48358 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | BRIP1 CDCA2 KCNK6 RAD51 NUP107 TROAP STIL RET ATAD2 E2F8 SPAG5 CELSR2 | 6.00e-05 | 323 | 246 | 12 | M2156 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | TSPOAP1 KDM5C ITGB5 DHX9 NUP210 FLNC POLR2A XPC CELSR2 CSPG5 SORL1 | 6.52e-05 | 276 | 246 | 11 | M3063 |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_CD1_UP | 7.00e-05 | 46 | 246 | 5 | M1190 | |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | 7.27e-05 | 187 | 246 | 9 | M6807 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | BRIP1 KIF1A DHX9 CDCA2 SCN8A RAB39B GP1BB RAD51 TROAP STIL ATAD2 RFX3 E2F8 SPAG5 CELSR2 CSPG5 TRIM37 TP53BP1 | 8.38e-05 | 680 | 246 | 18 | MM456 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | EPPK1 QPCTL HLA-B SHISA5 DDOST PTPRS PIGO VCP TAF1D FLNC LAMB1 CPD SLC45A4 TGFBR3 HELZ2 PCDH1 MSLN XPOT | 8.54e-05 | 681 | 246 | 18 | M5314 |
| Coexpression | BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE | 8.61e-05 | 48 | 246 | 5 | M40000 | |
| Coexpression | GSE3982_BCELL_VS_NKCELL_DN | 1.08e-04 | 197 | 246 | 9 | M5548 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 1.17e-04 | 199 | 246 | 9 | M9124 | |
| Coexpression | GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN | 1.21e-04 | 200 | 246 | 9 | M3575 | |
| Coexpression | GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP | HLA-B HLA-DRB1 HLA-G ITGB5 SERPINB12 RASA3 WDFY4 KIAA1614 WFIKKN2 | 1.21e-04 | 200 | 246 | 9 | M6207 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN COL22A1 ADGRV1 PKD1L2 DSCAML1 SCN2A PTPRQ PCDH10 FAT4 DNAH10 FAT3 PKHD1L1 HMCN1 CSMD1 HYDIN | 1.42e-13 | 184 | 247 | 15 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN COL22A1 ADGRV1 PKD1L2 DSCAML1 SCN2A PTPRQ PCDH10 FAT4 DNAH10 FAT3 PKHD1L1 HMCN1 CSMD1 HYDIN | 1.42e-13 | 184 | 247 | 15 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN COL22A1 ADGRV1 PKD1L2 DSCAML1 SCN2A PTPRQ PCDH10 FAT4 DNAH10 FAT3 PKHD1L1 HMCN1 CSMD1 HYDIN | 1.42e-13 | 184 | 247 | 15 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | CDK14 SVEP1 ADAMTS17 PZP CNTN4 COL6A3 PCDHGB5 SYNE1 LAMB1 CCDC80 TGFBR3 MACF1 PALLD | 1.00e-10 | 199 | 247 | 13 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL22A1 ADGRV1 DSCAML1 SVEP1 MOV10L1 PTPRQ CNTN4 DNAH10 FAT3 PKHD1L1 HMCN1 HYDIN | 1.08e-10 | 160 | 247 | 12 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL22A1 ADGRV1 DSCAML1 SVEP1 MOV10L1 PTPRQ CNTN4 DNAH10 FAT3 PKHD1L1 HMCN1 HYDIN | 1.08e-10 | 160 | 247 | 12 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | CDK14 SVEP1 PZP COL6A3 PCDHGB5 SYNE1 LAMB1 CCDC80 AKAP12 TGFBR3 MACF1 PALLD | 1.33e-09 | 199 | 247 | 12 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | SVEP1 PTPRS ADAMTS17 COL6A3 FAT4 FAT3 LAMB1 HMCN1 MACF1 ARHGAP28 PALLD | 1.06e-08 | 191 | 247 | 11 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | SVEP1 PTPRS NNMT COL6A3 FAT3 LAMB1 AKAP12 TGFBR3 HMCN1 ARHGAP28 PALLD | 1.38e-08 | 196 | 247 | 11 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | SVEP1 PTPRS ADAMTS17 COL6A3 FAT3 LAMB1 CCDC80 HMCN1 MACF1 ARHGAP28 PALLD | 1.38e-08 | 196 | 247 | 11 | 7d8505dac15fa59935ccf592afc54b04c4c6554f |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | FILIP1 SVEP1 NNMT COL6A3 FAT4 RASA3 SYNE1 CCDC80 AKAP12 ATRNL1 PALLD | 1.46e-08 | 197 | 247 | 11 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | FILIP1 SVEP1 NNMT COL6A3 FAT4 RASA3 SYNE1 CCDC80 AKAP12 ATRNL1 PALLD | 1.53e-08 | 198 | 247 | 11 | a860246bcea847249a78fd2e86ed8e04371060db |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | CDK14 SVEP1 PZP COL6A3 PCDHGB5 SYNE1 LAMB1 CCDC80 AKAP12 MACF1 PALLD | 1.62e-08 | 199 | 247 | 11 | e1849505b92820a219c5a2c35492bdd55579fb48 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | CDK14 SVEP1 ADAMTS17 PZP CNTN4 COL6A3 RASA3 SYNE1 LAMB1 CCDC80 PALLD | 1.62e-08 | 199 | 247 | 11 | 8b86c69aaf60feff53aa782559cfece7342a23de |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | CDK14 SVEP1 PZP COL6A3 PCDHGB5 SYNE1 LAMB1 CCDC80 AKAP12 MACF1 PALLD | 1.70e-08 | 200 | 247 | 11 | 44a68bacdb3d5bf563bd35952176995850933a81 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SVEP1 PTPRS COL6A3 FAT4 FAT3 LAMB1 CCDC80 AKAP12 TGFBR3 HMCN1 ARHGAP28 | 1.70e-08 | 200 | 247 | 11 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | CDK14 SVEP1 PZP COL6A3 PCDHGB5 SYNE1 LAMB1 CCDC80 AKAP12 MACF1 PALLD | 1.70e-08 | 200 | 247 | 11 | dc61016c61729f69649cfb21f6264e685ce83dea |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 6.29e-08 | 178 | 247 | 10 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | SVEP1 PTPRS ADAMTS17 COL6A3 FAT3 LAMB1 HMCN1 MACF1 ARHGAP28 PALLD | 1.00e-07 | 187 | 247 | 10 | 92d468dde81125d51daf7abd4703741abe1ab91c |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | PTPRS ADAMTS17 COL6A3 FAT3 LAMB1 CCDC80 AKAP12 HMCN1 MACF1 PALLD | 1.16e-07 | 190 | 247 | 10 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | SVEP1 PTPRS ADAMTS17 COL6A3 FAT3 LAMB1 HMCN1 MACF1 ARHGAP28 PALLD | 1.28e-07 | 192 | 247 | 10 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CDK14 SVEP1 ADAMTS17 PZP CNTN4 COL6A3 FAT3 LAMB1 CCDC80 PALLD | 1.28e-07 | 192 | 247 | 10 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | SVEP1 PTPRS ADAMTS17 COL6A3 FAT3 LAMB1 HMCN1 MACF1 ARHGAP28 PALLD | 1.34e-07 | 193 | 247 | 10 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-07 | 194 | 247 | 10 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | PND07-28-samps-Mesenchymal|PND07-28-samps / Age Group, Lineage, Cell class and subclass | PTPRS ADAMTS17 NNMT COL6A3 LAMB1 CCDC80 AKAP12 TGFBR3 HMCN1 PALLD | 1.41e-07 | 194 | 247 | 10 | 68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | SVEP1 PZP COL6A3 PCDHGB5 SYNE1 LAMB1 CCDC80 AKAP12 MACF1 DNAI7 | 1.63e-07 | 197 | 247 | 10 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | CDK14 SVEP1 PZP COL6A3 LAMB1 CCDC80 AKAP12 MACF1 ARHGAP28 PALLD | 1.70e-07 | 198 | 247 | 10 | 0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | CDK14 SVEP1 COL6A3 FAT4 FAT3 LAMB1 CCDC80 AKAP12 HMCN1 ARHGAP28 | 1.70e-07 | 198 | 247 | 10 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | FILIP1 SVEP1 PTPRS NNMT COL6A3 COMP LAMB1 CCDC80 AKAP12 TGFBR3 | 1.79e-07 | 199 | 247 | 10 | 13ff7409e200a0b46cdb7924d15ef33639693622 |
| ToppCell | TCGA-Cervix-Primary_Tumor|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.79e-07 | 199 | 247 | 10 | ef6fde26af2ca9e6cde198ac0e14e03d9ab398f8 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | SVEP1 PTPRS COL6A3 FAT4 FAT3 LAMB1 CCDC80 AKAP12 HMCN1 ARHGAP28 | 1.79e-07 | 199 | 247 | 10 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.79e-07 | 199 | 247 | 10 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | SVEP1 PZP CNTN4 COL6A3 PCDHGB5 SYNE1 LAMB1 CCDC80 AKAP12 MACF1 | 1.87e-07 | 200 | 247 | 10 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | CDK14 SVEP1 PZP COL6A3 SYNE1 LAMB1 CCDC80 AKAP12 MACF1 PALLD | 1.87e-07 | 200 | 247 | 10 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | CDK14 SVEP1 PZP COL6A3 SYNE1 LAMB1 CCDC80 AKAP12 MACF1 PALLD | 1.87e-07 | 200 | 247 | 10 | 50ca6550998e461ef26dd670351060bd940765a8 |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SVEP1 PTPRS COL6A3 FAT3 LAMB1 CCDC80 AKAP12 TGFBR3 HMCN1 ARHGAP28 | 1.87e-07 | 200 | 247 | 10 | 389cc775c8419d90fb77cd794376d2160a7bf44e |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.87e-07 | 200 | 247 | 10 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | SVEP1 PTPRS COL6A3 FAT4 FAT3 LAMB1 HMCN1 MACF1 ARHGAP28 PALLD | 1.87e-07 | 200 | 247 | 10 | aa1a35dcca3b799241eef4237f6eb94660e019f0 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | SVEP1 PTPRS COL6A3 FAT4 FAT3 LAMB1 HMCN1 MACF1 ARHGAP28 PALLD | 1.87e-07 | 200 | 247 | 10 | a510deaada669e690329183e18df02870bd204b3 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SVEP1 NNMT COL6A3 FAT4 SYNE1 LAMB1 CCDC80 AKAP12 TGFBR3 HMCN1 | 1.87e-07 | 200 | 247 | 10 | b4ccffdd79526c85e5273d27b668dbddcddba1ee |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CPAMD8 SVEP1 NNMT COL6A3 FAT4 SYNE1 LAMB1 CCDC80 AKAP12 TGFBR3 | 1.87e-07 | 200 | 247 | 10 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | CDK14 SVEP1 PZP COL6A3 SYNE1 LAMB1 CCDC80 AKAP12 MACF1 PALLD | 1.87e-07 | 200 | 247 | 10 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | CPAMD8 SVEP1 PZP COL6A3 PCDHGB5 SYNE1 LAMB1 CCDC80 AKAP12 MACF1 | 1.87e-07 | 200 | 247 | 10 | bd8cf33502adea320e91ca2af14e1911d88ad374 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SVEP1 PTPRS COL6A3 FAT4 FAT3 LAMB1 HMCN1 MACF1 ARHGAP28 PALLD | 1.87e-07 | 200 | 247 | 10 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-07 | 155 | 247 | 9 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | SVEP1 ADAMTS17 AMIGO2 COL6A3 PCDHA8 GRIN2C KIAA1614 MACF1 PALLD | 3.36e-07 | 163 | 247 | 9 | f1ec2625b52664308968b01d8e0275e1e0751480 |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.79e-07 | 170 | 247 | 9 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-07 | 171 | 247 | 9 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-07 | 171 | 247 | 9 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4-Gpr17_(Bmp4)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.13e-07 | 86 | 247 | 7 | eb2b9e98ff97371f497ee1709848a2caaa46ed3d | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4-Gpr17_(Bmp4)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.13e-07 | 86 | 247 | 7 | 02ea5219e2faded2b50b96d41861e4f8a558e4e3 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.28e-07 | 172 | 247 | 9 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-07 | 174 | 247 | 9 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-07 | 181 | 247 | 9 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-07 | 181 | 247 | 9 | cef034030e6b029a49ae56be37ea1fac1a5c350e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-07 | 181 | 247 | 9 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.10e-07 | 181 | 247 | 9 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.10e-07 | 181 | 247 | 9 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-07 | 181 | 247 | 9 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.48e-07 | 182 | 247 | 9 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.88e-07 | 183 | 247 | 9 | a90ffd9c50caa65f537a2e441e37655e1b622327 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.88e-07 | 183 | 247 | 9 | 13ad20ec140ef5b96fdace3369b5befc0f40bb76 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-07 | 183 | 247 | 9 | 6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 8.88e-07 | 183 | 247 | 9 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-06 | 187 | 247 | 9 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-06 | 188 | 247 | 9 | bd091503f580dedab40e0996273101285d24b586 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.16e-06 | 189 | 247 | 9 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-06 | 189 | 247 | 9 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-06 | 190 | 247 | 9 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-06 | 190 | 247 | 9 | 6f71a9f74af7cd9a674753cfc9833ebe5bba0fa2 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-06 | 191 | 247 | 9 | 9d7d680da3979e256191b534ebd14c5383e0cf93 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-06 | 191 | 247 | 9 | 543da1197c7e62f2c9cbd4a51414bbaaa6d1a92f | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-06 | 192 | 247 | 9 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.32e-06 | 192 | 247 | 9 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.32e-06 | 192 | 247 | 9 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-06 | 192 | 247 | 9 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.32e-06 | 192 | 247 | 9 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.32e-06 | 192 | 247 | 9 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.38e-06 | 193 | 247 | 9 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 193 | 247 | 9 | d0a5f212f8e8a13dbbe3e41df92548ef82eef70b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.38e-06 | 193 | 247 | 9 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.38e-06 | 193 | 247 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | SVEP1 PTPRS ADAMTS17 COL6A3 FAT3 LAMB1 TGFBR3 ARHGAP28 PALLD | 1.44e-06 | 194 | 247 | 9 | e93de9428c986b8943fc169258847c650cfab0e5 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-06 | 194 | 247 | 9 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-06 | 194 | 247 | 9 | 421344cc4b601d9745fa72d0af3124dab11d1d27 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.44e-06 | 194 | 247 | 9 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.44e-06 | 194 | 247 | 9 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.50e-06 | 195 | 247 | 9 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-06 | 195 | 247 | 9 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-06 | 195 | 247 | 9 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-06 | 195 | 247 | 9 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-06 | 195 | 247 | 9 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.50e-06 | 195 | 247 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.50e-06 | 195 | 247 | 9 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-06 | 195 | 247 | 9 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.50e-06 | 195 | 247 | 9 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-06 | 195 | 247 | 9 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 145 | 247 | 8 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-06 | 196 | 247 | 9 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.57e-06 | 196 | 247 | 9 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| Computational | Genes in the cancer module 412. | 2.12e-05 | 13 | 146 | 4 | MODULE_412 | |
| Computational | Genes in the cancer module 275. | 5.24e-05 | 16 | 146 | 4 | MODULE_275 | |
| Disease | Colorectal Carcinoma | CYP1A2 CPAMD8 BCAS2 APC2 MCF2L2 OBSCN DSCAML1 PTPRS SESN2 PZP PIGO CNTN4 FLNC MTHFD1L SYNE1 RET MFN1 AKAP12 ICAM5 DCHS1 SCN3B SORL1 | 7.63e-08 | 702 | 239 | 22 | C0009402 |
| Disease | Internal Carotid Artery Thrombosis | 2.09e-06 | 4 | 239 | 3 | C0750990 | |
| Disease | Common Carotid Artery Thrombosis | 2.09e-06 | 4 | 239 | 3 | C0750988 | |
| Disease | External Carotid Artery Thrombosis | 2.09e-06 | 4 | 239 | 3 | C0750989 | |
| Disease | Carotid Artery Thrombosis | 2.09e-06 | 4 | 239 | 3 | C0007274 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | HLA-B HLA-DRB1 TSC22D2 DNAH10 RASA3 IFI35 LLGL2 CELSR2 MACF1 PCCB TP53BP1 | 2.40e-06 | 224 | 239 | 11 | EFO_0004530, EFO_0008317 |
| Disease | epilepsy (implicated_via_orthology) | 7.83e-06 | 163 | 239 | 9 | DOID:1826 (implicated_via_orthology) | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 9.65e-06 | 127 | 239 | 8 | EFO_0008595, EFO_0020947 | |
| Disease | Autistic Disorder | KIF1A KDM5C HLA-DRB1 ITGB3 RAB39B PCDH10 NOS2 CNTN4 LAMB1 XPC WDFY4 | 1.03e-05 | 261 | 239 | 11 | C0004352 |
| Disease | FNAITP | 1.03e-05 | 6 | 239 | 3 | C3854603 | |
| Disease | Neonatal Alloimmune Thrombocytopenia | 1.03e-05 | 6 | 239 | 3 | C3853779 | |
| Disease | Autosomal dominant macrothrombocytopenia | 1.79e-05 | 7 | 239 | 3 | C4304021 | |
| Disease | retinal detachment | 1.79e-05 | 7 | 239 | 3 | EFO_0005773 | |
| Disease | Malignant neoplasm of breast | HIC1 BRIP1 ADAT3 APC2 MCF2L2 OBSCN BOD1L1 ADGRF4 HERC2 NOS2 DNMT3A RAD51 SYNE1 UBR4 GRIN2D AKAP12 LLGL2 ICAM5 MACF1 PCDH8 TP53BP1 DOP1A SORL1 | 2.38e-05 | 1074 | 239 | 23 | C0006142 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | HLA-B HLA-DRB1 HLA-G DOCK6 DNAH10 CELSR2 HELZ2 MACF1 PCCB TP53BP1 MYBPC3 | 2.81e-05 | 291 | 239 | 11 | EFO_0008317, EFO_0020946 |
| Disease | free cholesterol to total lipids in large LDL percentage | 3.10e-05 | 74 | 239 | 6 | EFO_0022280 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | HLA-B HLA-DRB1 HLA-G TSC22D2 DNAH10 CELSR2 MACF1 PCCB TP53BP1 | 3.97e-05 | 200 | 239 | 9 | EFO_0004611, EFO_0020945 |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 4.25e-05 | 9 | 239 | 3 | C3502809 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 6.04e-05 | 10 | 239 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 6.04e-05 | 10 | 239 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | platelet-type bleeding disorder 16 (implicated_via_orthology) | 6.53e-05 | 2 | 239 | 2 | DOID:0060691 (implicated_via_orthology) | |
| Disease | Van Maldergem Wetzburger Verloes syndrome | 6.53e-05 | 2 | 239 | 2 | C1832390 | |
| Disease | Van Maldergem syndrome | 6.53e-05 | 2 | 239 | 2 | cv:C1832390 | |
| Disease | platelet-type bleeding disorder 16 (is_marker_for) | 6.53e-05 | 2 | 239 | 2 | DOID:0060691 (is_marker_for) | |
| Disease | Periventricular gray matter heterotopia | 6.53e-05 | 2 | 239 | 2 | C1849173 | |
| Disease | Glanzmann Thrombasthenia, Type A | 6.53e-05 | 2 | 239 | 2 | C3179396 | |
| Disease | platelet-type bleeding disorder 16 (is_implicated_in) | 6.53e-05 | 2 | 239 | 2 | DOID:0060691 (is_implicated_in) | |
| Disease | Glanzmann Thrombasthenia, Autosomal Dominant | 6.53e-05 | 2 | 239 | 2 | C1861195 | |
| Disease | Thrombasthenia | 6.53e-05 | 2 | 239 | 2 | C0040015 | |
| Disease | 1,5 anhydroglucitol measurement | 8.50e-05 | 29 | 239 | 4 | EFO_0008009 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 8.88e-05 | 222 | 239 | 9 | EFO_0008317, EFO_0020943 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.09e-04 | 12 | 239 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | cutaneous melanoma, hair color | 1.49e-04 | 62 | 239 | 5 | EFO_0000389, EFO_0003924 | |
| Disease | cholesterol in large VLDL measurement | 1.86e-04 | 65 | 239 | 5 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 1.86e-04 | 65 | 239 | 5 | EFO_0022230 | |
| Disease | Benign familial infantile epilepsy | 1.95e-04 | 3 | 239 | 2 | cv:C5575231 | |
| Disease | Joint Instability | 1.95e-04 | 3 | 239 | 2 | C0022410 | |
| Disease | Glanzmann's thrombasthenia (is_implicated_in) | 1.95e-04 | 3 | 239 | 2 | DOID:2219 (is_implicated_in) | |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 1.95e-04 | 3 | 239 | 2 | C1842563 | |
| Disease | Joint laxity | 1.95e-04 | 3 | 239 | 2 | C0086437 | |
| Disease | total lipids in small VLDL | 2.15e-04 | 67 | 239 | 5 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 2.15e-04 | 67 | 239 | 5 | EFO_0022175 | |
| Disease | free cholesterol in large VLDL measurement | 2.30e-04 | 68 | 239 | 5 | EFO_0022265 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.31e-04 | 150 | 239 | 7 | EFO_0004611, EFO_0020947 | |
| Disease | phosphatidylcholine 32:1 measurement | 2.50e-04 | 38 | 239 | 4 | EFO_0010373 | |
| Disease | Epilepsy | 2.68e-04 | 109 | 239 | 6 | C0014544 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 3.24e-04 | 264 | 239 | 9 | EFO_0008317, EFO_0020944 | |
| Disease | muscular dystrophy (is_implicated_in) | 3.28e-04 | 17 | 239 | 3 | DOID:9884 (is_implicated_in) | |
| Disease | intellectual disability (implicated_via_orthology) | 3.64e-04 | 75 | 239 | 5 | DOID:1059 (implicated_via_orthology) | |
| Disease | Takayasu Arteritis | 3.88e-04 | 4 | 239 | 2 | C0039263 | |
| Disease | triglycerides in large LDL measurement | 4.04e-04 | 43 | 239 | 4 | EFO_0022319 | |
| Disease | glycoprotein measurement | 4.29e-04 | 119 | 239 | 6 | EFO_0004555 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | HLA-B HLA-DRB1 TSC22D2 DOCK6 DNAH10 CELSR2 MACF1 PCCB TP53BP1 | 4.47e-04 | 276 | 239 | 9 | EFO_0004612, EFO_0020943 |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 4.69e-04 | 121 | 239 | 6 | EFO_0008595, EFO_0020943 | |
| Disease | Epilepsy, Cryptogenic | 5.49e-04 | 82 | 239 | 5 | C0086237 | |
| Disease | Awakening Epilepsy | 5.49e-04 | 82 | 239 | 5 | C0751111 | |
| Disease | Aura | 5.49e-04 | 82 | 239 | 5 | C0236018 | |
| Disease | lung cancer | 6.27e-04 | 21 | 239 | 3 | MONDO_0008903 | |
| Disease | allergic asthma (is_implicated_in) | 6.43e-04 | 5 | 239 | 2 | DOID:9415 (is_implicated_in) | |
| Disease | Cerebellar Ataxia | 6.43e-04 | 5 | 239 | 2 | C0007758 | |
| Disease | mucositis (biomarker_via_orthology) | 6.43e-04 | 5 | 239 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | Primary microcephaly | 7.21e-04 | 22 | 239 | 3 | C0431350 | |
| Disease | fatty acid measurement | HLA-B HLA-DRB1 DSCAML1 DOCK6 UBE3B IFI35 CELSR2 GPR61 MACF1 PCCB TP53BP1 | 9.24e-04 | 436 | 239 | 11 | EFO_0005110 |
| Disease | dietary heme iron intake measurement, type 2 diabetes mellitus | 9.59e-04 | 6 | 239 | 2 | EFO_0008355, MONDO_0005148 | |
| Disease | chemotherapy-induced cytotoxicity measurement | 9.59e-04 | 6 | 239 | 2 | EFO_0010978 | |
| Disease | body mass index, vital capacity | 9.59e-04 | 6 | 239 | 2 | EFO_0004312, EFO_0004340 | |
| Disease | Familial benign neonatal epilepsy | 9.59e-04 | 6 | 239 | 2 | C0220669 | |
| Disease | Meniere's disease (is_implicated_in) | 9.59e-04 | 6 | 239 | 2 | DOID:9849 (is_implicated_in) | |
| Disease | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | 9.59e-04 | 6 | 239 | 2 | C3888239 | |
| Disease | Lissencephaly | 9.59e-04 | 6 | 239 | 2 | C0266463 | |
| Disease | Acute Cerebrovascular Accidents | 9.66e-04 | 54 | 239 | 4 | C0751956 | |
| Disease | Hepatomegaly | 9.66e-04 | 54 | 239 | 4 | C0019209 | |
| Disease | diet measurement | CYP1A2 QPCTL HLA-B PRSS16 CLVS1 ZNF469 NWD2 DHH CNTN5 SCN2A PCDH10 DNMT3A LINC01559 RFX3 CELSR2 IGSF9B CSMD1 PCCB SORL1 | 9.70e-04 | 1049 | 239 | 19 | EFO_0008111 |
| Disease | triglycerides in medium VLDL measurement | 1.04e-03 | 55 | 239 | 4 | EFO_0022155 | |
| Disease | triglycerides in LDL measurement | 1.11e-03 | 56 | 239 | 4 | EFO_0022320 | |
| Disease | Intellectual Disability | KDM5C APC2 SCN1A NXF5 SCN8A RAB39B DNMT3A SYNE1 RTTN GRIN2D MACF1 | 1.13e-03 | 447 | 239 | 11 | C3714756 |
| Disease | platelet measurement | 1.14e-03 | 315 | 239 | 9 | EFO_0005036 | |
| Disease | Hypertrophic Cardiomyopathy | 1.18e-03 | 57 | 239 | 4 | C0007194 | |
| Disease | Acute monocytic leukemia | 1.19e-03 | 26 | 239 | 3 | C0023465 | |
| Disease | triglycerides in IDL measurement | 1.26e-03 | 58 | 239 | 4 | EFO_0022149 | |
| Disease | thrombocytopenia (is_implicated_in) | 1.33e-03 | 27 | 239 | 3 | DOID:1588 (is_implicated_in) | |
| Disease | Seizure, Febrile, Complex | 1.34e-03 | 7 | 239 | 2 | C0751057 | |
| Disease | Seizure, Febrile, Simple | 1.34e-03 | 7 | 239 | 2 | C0149886 | |
| Disease | retinopathy of prematurity (is_implicated_in) | 1.34e-03 | 7 | 239 | 2 | DOID:13025 (is_implicated_in) | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 1.34e-03 | 7 | 239 | 2 | DOID:0081267 (implicated_via_orthology) | |
| Disease | severe acute respiratory syndrome (is_implicated_in) | 1.34e-03 | 7 | 239 | 2 | DOID:2945 (is_implicated_in) | |
| Disease | very low density lipoprotein cholesterol measurement | 1.34e-03 | 260 | 239 | 8 | EFO_0008317 | |
| Disease | triglycerides to total lipids in small LDL percentage | 1.35e-03 | 59 | 239 | 4 | EFO_0022337 | |
| Disease | phospholipids in VLDL measurement | 1.35e-03 | 59 | 239 | 4 | EFO_0022301 | |
| Disease | pancreatic cancer (is_marker_for) | 1.41e-03 | 101 | 239 | 5 | DOID:1793 (is_marker_for) | |
| Disease | total lipids in VLDL measurement | 1.43e-03 | 60 | 239 | 4 | EFO_0022314 | |
| Disease | Cerebral Hemorrhage | 1.48e-03 | 28 | 239 | 3 | C2937358 | |
| Disease | non-melanoma skin carcinoma | 1.51e-03 | 265 | 239 | 8 | EFO_0009260 | |
| Disease | triglycerides in small VLDL measurement | 1.53e-03 | 61 | 239 | 4 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 1.53e-03 | 61 | 239 | 4 | EFO_0022274 | |
| Disease | free cholesterol in VLDL measurement | 1.53e-03 | 61 | 239 | 4 | EFO_0022276 | |
| Disease | Breast Carcinoma | HIC1 BRIP1 APC2 HERC2 NOS2 DNMT3A RAD51 SYNE1 AKAP12 LLGL2 ICAM5 TP53BP1 | 1.57e-03 | 538 | 239 | 12 | C0678222 |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.59e-03 | 153 | 239 | 6 | EFO_0004611, EFO_0020946 | |
| Disease | triglycerides in small HDL measurement | 1.62e-03 | 62 | 239 | 4 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 1.62e-03 | 62 | 239 | 4 | EFO_0022169 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GAVVVDPASDRVLAT | 196 | Q96EY9 | |
| APNVVLVVSDSFDGR | 31 | Q6UWY0 | |
| EAVARASLIPEFSDG | 321 | Q9Y5Z0 | |
| ITEDGSFSEPVARLT | 986 | Q96PZ7 | |
| VPAREAGSAVEAEEL | 31 | O95196 | |
| AAETLPEASRAVENG | 121 | Q9Y6K1 | |
| EAIDEGIAAATIFSP | 181 | Q9BXI3 | |
| GIAAATIFSPSRDVV | 186 | Q9BXI3 | |
| SVDAPVTDVGFLRAQ | 246 | Q9BUH8 | |
| RTGAAATPEEFEAIA | 111 | Q8N6M5 | |
| RGDTVVSEAELTPEA | 961 | Q02952 | |
| FVDPSLTVRADIAGR | 121 | Q8TD06 | |
| FRAFQTVVLDPEGDA | 531 | P49747 | |
| DFVLAVDTEGLRAPE | 1536 | Q7Z2Y8 | |
| ETGLITVREPLDFEA | 301 | Q6V0I7 | |
| ARAVAPSIIFFDELD | 716 | Q8NB90 | |
| DFRAPETIESVAQGI | 121 | Q8IZF3 | |
| FEPGEREATIAVNIL | 3596 | Q8WXG9 | |
| AFAADIPRILVAGDS | 146 | O95782 | |
| NAELSVIAVGPDFSR | 396 | Q8IWV2 | |
| IPVERAESTFLFLVG | 371 | P49753 | |
| FIPEASDDSGLEVRR | 2326 | Q5JWR5 | |
| ESESVFPREVGLFAD | 11 | Q96AZ1 | |
| GSLVIESPRFEDAGV | 346 | Q86SJ2 | |
| SIIFFDEIDGLAPVR | 526 | Q6PL18 | |
| EEGTPFTAIREASLL | 171 | O94921 | |
| IGLAVARVTATDPDE | 936 | Q9HCU4 | |
| TRTGDVLLAEPADFE | 51 | Q9UHI6 | |
| FVPEGSDLDKVAAER | 416 | Q8IYB7 | |
| SKIPEGEAVTAAEFR | 161 | P18075 | |
| DFILPISDVRASIGA | 926 | Q6UB35 | |
| ETPESSFLIEGDIIR | 66 | Q6HA08 | |
| DDPPLVDAAVFVTRT | 331 | Q8TE56 | |
| LFPINGSSVVEREDV | 831 | Q76M96 | |
| ADSVSDEAELLVRGP | 656 | O94779 | |
| RGLPFTATAEEVVAF | 331 | Q6NXG1 | |
| RLDSRTGVAPDVFAE | 411 | Q01581 | |
| VRVFISANPEDTGAE | 41 | Q9ULI1 | |
| FPDKTEATIGVDFRE | 61 | Q14088 | |
| VSDPTVGVDFFSRLV | 36 | Q96DA2 | |
| ALSFPVESDVAPIAR | 521 | P20742 | |
| PVSSDDDRGFVDLII | 71 | Q6BCY4 | |
| GRVVPFISAIASAEV | 346 | Q14644 | |
| VDFGNVVATLDPRAA | 146 | Q9NXS2 | |
| DTEGTFRPERLLAVA | 161 | Q06609 | |
| VEAELPFRAGDVITV | 1786 | O95153 | |
| EFRPERFLTADGTAI | 426 | P05177 | |
| FGEISSPVIREAEVT | 6 | P57740 | |
| TTDEDLEIIFSRFGP | 251 | Q8WUA2 | |
| SLPVREDAQFGTVIA | 356 | Q9UN73 | |
| AGVPDTDAAFLLSIV | 281 | O95907 | |
| APALDAFVERVLAAG | 56 | Q9Y257 | |
| RDDLVLVDSPGTDVT | 171 | Q8IWA4 | |
| DVELVETRPAGDGTF | 251 | P17693 | |
| EVLEEFPSLRVSAGF | 881 | P35228 | |
| PSGEIVADSVRFQVD | 476 | Q6IE37 | |
| DAVLSDFVRSTGAEP | 6 | Q6GQQ9 | |
| SSEIRVFGAPEVLEN | 1706 | Q8TEM1 | |
| GDLEFVRRTVDFTSP | 4326 | Q99102 | |
| VFQPISGEDVRDVTA | 5276 | Q99102 | |
| NFLDAPAVRVTGADV | 316 | P11177 | |
| VRSAEGLDFEVSPRL | 2126 | Q96JQ0 | |
| RPISVFREANEDESG | 1081 | Q9Y4B6 | |
| SSLRDPAGIFELVEV | 16 | O95819 | |
| SLPVREDAQFGTVIA | 356 | Q9Y5H6 | |
| DFRIPGQIAEETSEF | 411 | Q9BZJ8 | |
| VISGEESLIAAREPF | 446 | Q9BXT6 | |
| AGTTDPEEATRLLAE | 471 | Q14244 | |
| RVIGFTVLTEADPAA | 331 | Q6P1M3 | |
| ASLIGADPREIIFTS | 111 | Q9Y697 | |
| GERLDIEVTAAPSAD | 246 | Q6A163 | |
| PEGVFAVARLTAEQL | 646 | Q14526 | |
| FIPVTDDLGAASIIA | 3496 | O95714 | |
| IIFFDEIDGLAPVRS | 501 | Q9ULI0 | |
| SEEVFVPRTALLGER | 261 | Q5VZ46 | |
| SLTDPLVAERAGTDE | 191 | P13224 | |
| SSLTGDPVFEDVARV | 206 | Q9BV94 | |
| PSVEAASIGFIVVID | 91 | Q86YR7 | |
| VFLDPADIATLEGIS | 306 | Q86V87 | |
| LSPDVTLEGDAFVAT | 271 | Q9UMF0 | |
| LVTGFPASLRLSEEE | 136 | P80217 | |
| DGRELSAPVIVDIDS | 246 | Q9H1B4 | |
| VQGPVDREDLSTLRF | 341 | Q08174 | |
| VPEGAARESLVALVS | 401 | O95206 | |
| EVDRAVFSDSLVPAL | 351 | Q6L8Q7 | |
| FSSLPLGREAVEAAV | 211 | P40261 | |
| LPQVDSAVVAEFGRI | 16 | Q86X83 | |
| ASLPVEFTIDARDAG | 1556 | Q14315 | |
| DIILPSSFERGSEVV | 46 | Q9UM44 | |
| NEVGEAFRSLVPAAV | 26 | Q9UDX5 | |
| DIEPSTEGEVIFRAL | 196 | P07942 | |
| IANVREAVESFAGSP | 131 | P30613 | |
| AAGRPVEVLADLFVT | 151 | A6NHZ5 | |
| DLPGRFVAESAEVLL | 191 | Q13421 | |
| AQPGTRFILEVAEDA | 146 | Q9Y5G0 | |
| AAPGTVVALFSVTDR | 371 | Q9P2E7 | |
| VLVAASSDIGDPLRE | 126 | P39656 | |
| DTELVETRPAGDRTF | 251 | P01889 | |
| VFALRPVGFRDSLEV | 441 | P18084 | |
| PLGATDTAVFDVRLS | 111 | Q96EY5 | |
| GVTRLLDAEDVDVPS | 266 | Q9UPN3 | |
| TPVFERGAVDAFLLS | 1431 | Q7Z442 | |
| RAEEIPEGASTLAFV | 31 | Q96RW7 | |
| GVRSAPISILTEEDA | 881 | Q9UMZ3 | |
| IEFDESAGAVLRIQP | 81 | Q13332 | |
| EGAVAVAEFIAESPR | 376 | O75864 | |
| FSDDNARAVITIGIP | 771 | Q9BX63 | |
| VREAAPSDAGEVVFS | 2796 | Q5VST9 | |
| LVIAETFPEDAGIFT | 506 | Q8WX93 | |
| AAVRGFVDDIIQPSS | 496 | P05166 | |
| APDELSFEVGDIVSV | 201 | O14559 | |
| EERATGPVLISTADF | 2176 | Q8NFC6 | |
| LDAGSVRFTVEKPDE | 1256 | O95996 | |
| DEAVRVTEGEFPSRI | 756 | Q8NFZ0 | |
| EEFIAIDISGRDPAV | 3296 | Q4G0P3 | |
| SLVVSPGDTAEFDVV | 3561 | Q4G0P3 | |
| TDAAVAEVRPSLEVG | 1136 | Q9Y2F5 | |
| VELPGVEFRAASVNS | 246 | A0AVK6 | |
| APGSVDDEVSRILAS | 891 | Q96HP0 | |
| GDFVSDEVVAPVRET | 356 | O14981 | |
| PEDALVSVSARFLEE | 2961 | Q9UFH2 | |
| VSVSARFLEETEGIP | 2966 | Q9UFH2 | |
| AEVRETLGSLPDDFV | 916 | O75460 | |
| VAREEAVGVFAPLTA | 316 | O43323 | |
| QDFAIIALEDGTPRI | 396 | Q8TD84 | |
| VSPLGSIATRFLEEE | 656 | Q96MT8 | |
| RTEGFSVTLDDLAPD | 486 | P29317 | |
| VDSEALARVGPAELS | 481 | Q8IVF7 | |
| EGFLVDTPLARALVA | 211 | Q6P531 | |
| ETSVLDPDEGIRFRG | 81 | O75390 | |
| TRVDDGVASFVLNLP | 411 | P01031 | |
| AAPSVFRAGVEEVIS | 36 | Q8IZJ3 | |
| VEEVASEIQPFLRGA | 2001 | P15924 | |
| IDDFVSGVPRAARTL | 266 | P06756 | |
| DIVFLIDSSEGVRPD | 1436 | P12111 | |
| SLRVIRTDFGDPAVV | 1251 | Q8N1P7 | |
| ENPLEGDVSIFVRAL | 2561 | Q8TDW7 | |
| VVKEGPATEVDFSLR | 446 | O75976 | |
| GRIVPLDSEDSLSFV | 436 | Q5TEA3 | |
| GFEIPRILATSDIAV | 236 | Q6TDU7 | |
| SDVGEFRAVTELGRP | 71 | P01911 | |
| SRPFASVDVALEVGA | 1276 | Q5VV63 | |
| VANLVDTFEVGPDRT | 61 | Q8NFW1 | |
| AGDPVAVEALLRAVF | 11 | Q9Y600 | |
| KRVTFGEDLSPEVFD | 391 | Q69YH5 | |
| SRDFTLEEVSPDGEL | 76 | P32019 | |
| APESIEFPVSEARVL | 76 | P05106 | |
| FSDVDVARVLTPDAF | 211 | P03952 | |
| GPRVTVLVREFEAFD | 46 | Q9H9S5 | |
| VATEFVALVPDGARA | 121 | Q9H9S5 | |
| ASFVPRDGVLDVEAR | 1376 | Q9BYK8 | |
| EEPSTLERGAVFAIN | 651 | Q8IVF4 | |
| RDETGAIFIDRDPAA | 56 | Q9Y597 | |
| SAEGVTVEEPASERL | 1086 | Q5VV67 | |
| DIATGRAVEPESEFV | 121 | Q9H159 | |
| VSVAERVAFERGEEP | 451 | Q08211 | |
| FVSGERLVSDPAGEV | 246 | Q96QI5 | |
| FAPGSEEAIERLKET | 426 | Q12756 | |
| RASVGAVDPEAALVD | 681 | Q9UN75 | |
| SALRDPAGIFELVEV | 16 | Q8N4C8 | |
| IVASAGSVEELPAER | 1301 | Q96Q06 | |
| VAEARPGATAFLEEA | 46 | Q96C34 | |
| EGLIVVETSAASEFP | 211 | Q8N8U3 | |
| PGEAERVAFLVSRLT | 131 | Q6ICC9 | |
| VDRDPEVRFTSLGLG | 1376 | Q86VV8 | |
| AFIPVEEVLREGAES | 46 | P58004 | |
| PDLIDVDLVRGSAFA | 86 | Q8N3S3 | |
| IEVANPDGDFRLTIV | 856 | Q92673 | |
| FESAVDPGAVVDLLE | 61 | Q8N4H0 | |
| ADDFDTPRVVDAILG | 411 | Q9HA77 | |
| DAVVVAVFSGLPAVE | 836 | O94972 | |
| EEPERSRALGVALAF | 206 | Q16572 | |
| FLGSILTAVADEEPE | 921 | Q96R06 | |
| TAFGVTVEDSDLALP | 41 | O43765 | |
| DAFTIAETELGIPRL | 241 | Q8NF91 | |
| LATSVFSIAIPVDGD | 636 | O75157 | |
| SGEAAEEETPAVFIR | 811 | Q7Z7B0 | |
| EADVVLLVGTNPRFE | 396 | P28331 | |
| ASRALPEFGEVEISS | 326 | P48380 | |
| AGDSFIVSSEFPVRL | 231 | Q9H5J8 | |
| ERFLVPIESIERASG | 261 | Q14249 | |
| VFQEEAVTEALRAPG | 891 | O14841 | |
| EVTVEEGSLSPERLF | 306 | Q5VWT5 | |
| EEDGPREFLALVTVT | 246 | Q9ULN7 | |
| LTAIIEEAEEAPGAR | 2571 | P58107 | |
| RLTAIIEEAEEAPGA | 3106 | P58107 | |
| RLTAIIEEAEEAPGA | 4171 | P58107 | |
| LEAQAATGFVIDPVR | 4931 | P58107 | |
| VILSESRTGAEVPFF | 511 | O75448 | |
| VVREEPGTFSISFIE | 66 | Q9NW61 | |
| ASVEPVEQLGSALRF | 81 | Q8N114 | |
| AEVALDLVGDRTPTS | 611 | Q9UPS6 | |
| VAFSLRVEAPTTLGD | 121 | Q7Z5L0 | |
| GTLEIFEVDFRDPSL | 41 | Q9NQW1 | |
| VLAGTAEAIFTPLER | 126 | Q3SY17 | |
| EGIFISRVSEEGPAA | 756 | Q14160 | |
| FPASLVVAAEEGERE | 786 | P08514 | |
| ATEVFREELGARPDA | 241 | P20701 | |
| PGVREAAAALVEEET | 26 | O75934 | |
| PIAASLRDSGVEIFT | 206 | Q4LDE5 | |
| DIFDETRADLTGISP | 321 | Q96P63 | |
| LTVTVPIAVGESDFE | 1111 | P35498 | |
| FAVGSISPRDFIDLV | 101 | P59095 | |
| DAAVVRPGFLSTAEE | 31 | Q9BT30 | |
| NEESFPGRVRALVDT | 66 | Q495D7 | |
| ETDEAPLIFTARGET | 136 | Q96LP6 | |
| ITRPDIGFLRTDDAF | 61 | Q8IUQ0 | |
| VVLDFSADATEGPIR | 166 | Q5BKX6 | |
| FSEEENGVPIARAVL | 51 | Q9UJT1 | |
| EGVTLTVDRFDPGRE | 91 | Q15468 | |
| FVGVVLSSELPEDDR | 306 | Q8N0X7 | |
| GRFDREVDIGIPDAT | 361 | P55072 | |
| LREEPEFVTARAGES | 26 | Q9UPX0 | |
| ALAVTFRPDGAELAV | 546 | Q15269 | |
| EGSFAVPRSDSVAIL | 231 | Q9P2N2 | |
| RDTEAAELVPGVAEL | 1031 | Q9BXM0 | |
| EDREVLRVIFPTGDS | 961 | P24928 | |
| VDDEVLAEGSPRSLS | 421 | Q86VK4 | |
| ERRFDIPSSLVGVID | 71 | Q9NYB5 | |
| LTVTVPIAVGESDFE | 1101 | Q99250 | |
| EATPFVAEERVSFGL | 1276 | Q6ZS81 | |
| FVTAIDTRLSGLEAP | 386 | A0A1W2PR48 | |
| GTIEFVADPAALATI | 116 | Q12815 | |
| IPLRVTEEAGEDFTS | 141 | Q9NY72 | |
| TEPQFLGRAAAVSAE | 266 | Q9H1K6 | |
| VEESEGRRDSLFIPI | 591 | Q9UQD0 | |
| PEAEFESDSGVVLRR | 51 | Q9UH36 | |
| DIALGVFDVVVTDPS | 1911 | Q12888 | |
| VTLPDGTLFEARAEV | 2371 | Q86WI1 | |
| VTDPEDVLVGADSAR | 131 | A8MWL6 | |
| LGRDSPSAVFEQDLE | 891 | Q8NB14 | |
| QLPEVSLGRFDFDVS | 381 | Q9BZ71 | |
| LRVFDADVVPASGEL | 296 | P07949 | |
| APRELAEAESVGRVE | 1556 | Q96JG9 | |
| TLLARAVAGEADVPF | 386 | Q96TA2 | |
| GLLTFRDVAIEFSPE | 11 | Q05481 | |
| SLSPRVLEEETDGFV | 321 | Q7Z3V4 | |
| LRVVVADDGSEAPER | 46 | O14863 | |
| FDILSVVDLNPRGVD | 126 | O43592 | |
| VVAEARATPFLLGSF | 566 | Q8TEQ8 | |
| ALVISGREVFEFRPE | 286 | Q8WU90 | |
| EVVRDLTFAPDGSLI | 171 | Q9Y6I7 | |
| EPVLGDVRESTAFSR | 141 | Q01831 | |
| PVETFSEFLDVAGLL | 5151 | Q5T4S7 | |
| PKRFDVEVSVLGSEA | 331 | Q9BVG3 | |
| VASSAPVRAVLDFSE | 206 | Q9NQE7 | |
| GPLTFRDVAIEFSLE | 11 | Q8NEM1 | |
| AFREAITEAVEAPAA | 81 | Q8N5A5 | |
| VAARTPAVEGLTEAE | 31 | O43399 | |
| EGDASLFTRPEIVVF | 556 | Q03167 | |
| PTRSLEAFAEEVGAA | 21 | Q9UJK0 | |
| ELTEEPDSGRALVTV | 471 | Q8TEU8 | |
| PALGVAREEAVFEAA | 206 | Q6PF15 | |
| REVALTSFPEVAASA | 156 | Q2WGJ6 | |
| SAQDLRDPGSVIVAF | 1136 | P41229 | |
| VAAGSPAVFEAETER | 21 | Q14896 | |
| RSEIVDFSVPFVETG | 516 | Q14957 | |
| VFEDDSRAPAVAPIL | 116 | O15399 | |
| RSEIVDFSVPFVETG | 546 | O15399 |